Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prediction of tumor-infiltrating lymphocytes through habitat radiomics and exploration of response mechanisms in neoadjuvant immunochemotherapy-treated lung cancer. | Cancer Immunol Immunother | 2026 | 41591567 | PubTator, text mining | PubMed |
| PP2A dysfunction mediated by PPP2R1A deficiency drives cGAS-STING-dependent hyperinflammation in SLE CD14+ monocytes. | Clin Rheumatol | 2026 | 41582267 | PubTator, text mining | PubMed |
| Marginal zone lymphoma presenting with chylous ascites: A rare clinical manifestation and successful treatment with orelabrutinib-rituximab. | SAGE Open Med Case Rep | 2026 | 41551116 | PubTator, text mining | PubMed |
| Disordered DNA-binding motif forms a modulation site for inhibiting the cancer immunotherapy target TREX1. | Nucleic Acids Res | 2026 | 41533589 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis reveals IFIT3⁺ macrophage-associated ISG20 as a prognostic biomarker and elucidates underlying tumor-suppressive mechanisms in ovarian cancer. | J Ovarian Res | 2026 | 41514449 | PubTator, text mining | PubMed |
| Exonuclease ISG20 inhibits human cytomegalovirus replication by inducing an innate immune defense signature. | PLoS Pathog | 2026 | 41511982 | PubTator, text mining | PubMed |
| Identifying Immune Cells as Mediators in the Impact of Gut Microbiota on Congenital Malformations of the Nervous System. | Brain Behav | 2026 | 41474150 | PubTator, text mining | PubMed |
| m6A modification in the 3'‑leader region of EBOV genome antagonizes ISG20 to facilitate viral replication. | Int J Biol Macromol | 2026 | 41423124 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis reveals RNA-binding protein dysregulation in immune checkpoint inhibitor-induced colitis. | J Leukoc Biol | 2026 | 41392552 | PubTator, text mining | PubMed |
| HIF-1-mediated ISG20 expression promotes breast cancer stemness and immune evasion. | J Exp Med | 2026 | 41385111 | PubTator, text mining | PubMed |
| Comparison of anti-human T cell globulins on immune reconstitution and early infections after autologous transplant in patients with multiple sclerosis. | Bone Marrow Transplant | 2026 | 41310182 | PubTator, text mining | PubMed |
| Interplay between expression of PD-L1 on thyrocytes and intrathyroidal lymphocytes and FOXP3 as a marker of regulatory T lymphocytes in Hashimoto thyroiditis. | Am J Physiol Endocrinol Metab | 2026 | 41285166 | PubTator, text mining | PubMed |
| Role of donor regulatory T-cell adoptive immunotherapy in B-cell immunity after hematopoietic cell transplantation. | Haematologica | 2026 | 41195519 | PubTator, text mining | PubMed |
| IL1β signaling mediates the interaction between hepatitis B and C viruses. | Hepatology | 2026 | 40938198 | PubTator, text mining | PubMed |
| Immune cells influence major depression through metabolites: A Mendelian randomization analysis of bidirectional causality and mediating effects. | J Affect Disord | 2026 | 40925480 | PubTator, text mining | PubMed |
| Immunocytes Play a Crucial Role as Mediators in the Protective Effects of D-β-Hydroxybutyrate Dehydrogenase 1 against Type 2 Diabetes Mellitus: A Mendelian Randomization Study | Endocr Metab Immune Disord Drug Targets | 2026 | 40396311 | PubTator, text mining | PubMed |
| The strategies and advances of mRNA translation booster. | Asian J Pharm Sci | 2025 | 41809895 | PubTator, text mining | PubMed |
| Upregulation of interferon-γ activation in patients with anti-interferon-γ autoantibodies immunodeficiency syndrome: insights from single-cell analysis. | Front Immunol | 2025 | 41710026 | PubTator, text mining | PubMed |
| Global burden and genetic insights of RA and JIA in ages 0-19 years: GBD 2021 and MR analysis. | Front Immunol | 2025 | 41613114 | PubTator, text mining | PubMed |
| Evaluation of dasatinib and ponatinib for the control of CD123 CAR-T cell functionalities. | Mol Ther Oncol | 2025 | 41477551 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=4